Can rye intake decrease risk of human breast cancer?

Food and Nutrition Research

Volumn 54, Issue , 2010, Pages

  Adlercreutz, Herman ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alkylresorcinols; Fibre; Lignans; Oestrogens; Wholegrain

Indexed keywords

7 HYDROXYMATAIRESINOL; ALKYLRESORCINOL; ANDROGEN; BILE ACID; BUTYRIC ACID; ENTERODIOL; ENTEROLIGNAN; ESTROGEN; LARICIRESINOL; LIGNAN DERIVATIVE; MATAIRESINOL; MEDIORESINOL; PINORESINOL; RESORCINOL DERIVATIVE; SECOISOLARICIRESINOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DIETARY FIBER; DIETARY INTAKE; ESTERIFICATION; FERMENTATION; GENETIC POLYMORPHISM; HUMAN; INFORMATION RETRIEVAL; INTESTINE FLORA; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; REVIEW; RISK ASSESSMENT; RISK REDUCTION; RYE; SYSTEMATIC REVIEW;

SECALE CEREALE;

EID: 79251472159     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v54i0.5231     Document Type: Review

References (99)

1. Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the "fiber hypothesis". Gastroenterology 1984; 86: 761-4.
2. Marquart L, Jacobs DRJr, McIntosh GH, Poutanen K, Reicks M, eds., Whole grains & health. Carlton: Blackwell Publishing Asia; 2007, p. 335.
3. Glitsø LV, Mazur WM, Adlercreutz H, Wähälä K, Mäkelä T, Sandströom B, et al. Intestinal metabolism of rye lignans in pigs. Brit J Nutr 2000; 84: 429-37.
4. Lærke HN, Mortensen MA, Hedemann MS, Bach Knudsen KE, Penalvo JL, Adlercreutz H. Quantitative aspects of the metabolism of lignans in pigs fed fibre-enriched rye and wheat bread. Brit J Nutr 2009; 102: 985-94.
5. Egeberg R, Olsen A, Loft S, Christensen J, Johnsen NF, Overvad K, et al. Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women. Int J Cancer 2009; 124: 745-50.
6. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidem Biomark Prev 2004; 13: 2084-9. (Pubitemid 40054302)
7. Johnsen NF, Hausner H, Olsen A, Tetens I, Christensen J, Knudsen KE, et al. Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. J Nutr 2004; 134: 2691-7. (Pubitemid 39315274)
8. Chatenoud L, Tavani A, La Vecchia C, Jacobs DR Jr, Negri E, Levi F, et al. Whole grain food intake and cancer risk. Int J Cancer 1998; 77: 24-8. (Pubitemid 28308547)
9. Fung TT, Hu FB, Holmes MD, Rosner BA, Hunter DJ, Colditz GA, et al. Dietary patterns and the risk of postmenopausal breast cancer. Int J Cancer 2005; 116: 116-21. (Pubitemid 40827764)
10. Nicodemus KK, Jacobs DR Jr, Folsom AR. Whole and refined grain intake and risk of incident postmenopausal breast cancer (United States). Cancer Causes Control 2001; 12: 917-25. (Pubitemid 34048873)
11. Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc 2003; 62: 129-34. (Pubitemid 36569819)
12. Slavin J, Jacobs D, Marquart L. Whole-grain consumption and chronic disease: protective mechanisms. Nutr Cancer 1997; 27: 14-21. (Pubitemid 26424310)
13. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Molec Biol 2007; 106: 24-30. (Pubitemid 47371201)
14. Adlercreutz H. Estrogen excretion in human bile. Acta Endocr (Kbh) 1962; 42: 1-220.
15. Adlercreutz H, Martin F. Review: biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 1980; 13: 231-44. (Pubitemid 10079039)
16. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst 1994; 86: 1076-82. (Pubitemid 24228475)
17. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 1982; 307: 1542-7. (Pubitemid 13245428)
18. Aubertin-Leheudre M, Gorbach S, Woods M, Dwyer JT, Goldin B, Adlercreutz H. Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. J Steroid Biochem Molec Biol 2008; 112: 32-9.
19. Penalvo JL, Haajanen KM, Botting NP, Adlercreutz H. Quantification of lignans in food using isotope dilution gas chromatography-mass spectrometry. J Agric Food Chem 2005; 53: 9342-7. (Pubitemid 41784134)
20. Ross AB, Shepherd MJ, Schupphaus M, Sinclair V, Alfaro B, Kamal-Eldin A, et al. Alkylresorcinols in cereals and cereal products. J Agr Food Chem 2003; 51: 4111-8.
21. Adlercreutz H. Human health and phytoestrogens. In: Korach KS, ed. Reproductive and developmental toxicology. New York: Marcel Dekker; 1998. pp. 299-371.
22. Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Hämäläinen E, Wähälä K, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Molec Biol 1992; 41: 331-7.
23. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Molec Biol 1993; 44: 147-53. (Pubitemid 23072266)
24. Setchell KDR, Adlercreutz H. The excretion of two new phenolic compounds (180/442 and 180/410) during the human menstrual cycle and in pregnancy. J Steroid Biochem 1979; 11: xv-xvi.
25. Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and in animal species. Nature 1980; 287: 740-2. (Pubitemid 11216456)
26. Stitch SR, Toumba JK, Groen MB, Funke CW, Leemhuis J, Vink J, et al. Excretion, isolation and structure of a phenolic constituent of female urine. Nature 1980; 287: 738-40. (Pubitemid 11216455)
27. Nurmi T, Adlercreutz H. Sensitive high-performance liquid chromatographic method for profiling plasma phytoestrogens using coulometric electrode array detection. Application to plasma analysis. Anal Biochem 1999; 274: 110-7. (Pubitemid 29466361)
28. Nishibe S. Bioactive lignans and flavonoids from traditional medicines. In: Brouillard R, Jay M, Scalbert A, eds. 17th International Conference on Polyphenols, Palma de Mallorca (Spain). Paris: INRA Editions; 1994, pp. 113-22.
29. Sih CJ, Ravikumar PR, Huang FC, Buckner C, Whitlock H, Jr. Letter: isolation and synthesis of pinoresinol diglucoside, a major antihypertensive principle of Tu-Chung (Eucommia ulmoides, Oliver). J Am Chem Soc 1976; 98: 5412-3.
30. Adlercreutz H. Lignans and human health. Crit Rev Clin Lab Sci 2007; 44: 483-525. (Pubitemid 47619399)
31. Milder IEJ, Arts ICW, vandePutte B, Venema DP, Hollman PCH. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Brit J Nutr 2005; 93: 393-402.
32. Adlercreutz H, Fotsis T, Lampe J, Wähälä K, Mäkelä T, Brunow G, et al. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas-chromatography mass-spectrometry. Scand J Clin Lab Invest 1993; 53: 5-18. (Pubitemid 23204325)
33. Axelson M, Sjövall J, Gustafsson BE, Setchell KDR. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982; 298: 659-60. (Pubitemid 12099722)
34. Bannwart C, Adlercreutz H, Fotsis T, Wähälä K, Hase T, Brunow G. Identification of O-desmethylangolensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn Chem Lett 1984: 120-5.
35. Mazur W. Phytoestrogen content in foods. In: Adlercreutz H, ed., Phytoestrogens. Baillière's clinical endocrinology and metabolism. London: Baillière Tindall; 1998, vol. 12/Number 4, pp. 729-742.
36. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006; 54: 184-201. (Pubitemid 44316301)
37. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Rafaelli B, Wähälä K, et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 2001; 49: 3178-86. (Pubitemid 32845044)
38. Penalvo JL, Heinonen SM, Aura AM, Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. J Nutr 2005; 135: 1056-62. (Pubitemid 40645290)
39. Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, Fukushima K, et al. Dietary lignins are precursors of mammalian lignans in rats. J Nutr 2004; 134: 120-7. (Pubitemid 38057433)
40. Horner NK, Kristal AR, Prunty J, Skor HE, Potter JD, Lampe JW. Dietary determinants of plasma enterolactone. Cancer Epidem Biomarker Prev 2002; 11: 121-6. (Pubitemid 34118321)
41. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, Adlercreutz H. Determinants of serum enterolactone concentration. Amer J Clin Nutr 2001; 73: 1094-100. (Pubitemid 32496950)
42. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. Amer J Epidem 2002; 155: 472-7. (Pubitemid 34174159)
43. Pietinen P, Stumpf K, Männistö S, Kataja V, Adlercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidem Biomark Prev 2001; 70: 339-44. (Pubitemid 32703218)
44. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 1999; 354: 2112-5. (Pubitemid 30008894)
45. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone-Kuopio ischaemic heart disease risk factor study. Arch Intern Med 2003; 163: 1099-104. (Pubitemid 36548940)
46. Clavel T, Borrmann D, Braune A, Dore J, Blaut MU-hwscsaBWT-H-fcbdafcb. Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 2006; 12: 140-7. (Pubitemid 43831679)
47. Clavel T, Henderson G, Alpert CA, Philippe C, RigottierGois L, Dore J, et al. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol 2005; 71: 6077-85. (Pubitemid 41456904)
48. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 50: 3-23. (Pubitemid 20271058)
49. Adlercreutz H. Diet and sex hormone metabolism. In: Rowland IR, ed. Nutrition, toxicity, and cancer. Boca Raton: CRC Press; 1991. pp. 137-95.
50. Hallmans G, Zhang J-X, Lundin E, Bergh A, Landström M, Sylvan A, et al. Metabolism of lignans and their relation to experimental prostate cancer. In: S B-G, A K, F. S, eds. Cost 916 bioactive plant cell wall components in nutrition and health phyto-estrogens: exposure, bioavailability, health benefits and safety concerns. Doorwerth, The Netherlands: European Communities; 1999, pp. 65-72.
51. Bach Knudsen KE, Serena A, Adlercreutz H. Cereal fibre sources that enhance the production and plasma concentrations of enterolignans and butyrate. AgroFOOD industry high-tech 2007; 18: 46-7.
52. Thompson LU. Flaxseed, lignans, and cancer. In: Cunnane SC, Thompson LU, eds. Flaxseed in human nutrition. Champaign, IL: AOCS Press; 1995. pp. 219-36.
53. Thompson LU. Experimental studies on lignans and cancer. In: Adlercreutz H, ed. Bailliere's clinical endocrinology and metabolism, vol. 12. London: Bailliere Tindall; 1998. pp. 691-705.
54. Tou JCL, Thompson LU. Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 1999; 20: 1831-5. (Pubitemid 29410565)
55. Ward WE, Jiang FO, Thompson LU. Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr Cancer 2000; 37: 187-92.
56. Tan KP, Chen JM, Ward WE, Thompson LU. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med 2004; 229: 147-57. (Pubitemid 38146558)
57. Chen JM, Tan KP, Ward WE, Thompson LU. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med 2003; 228: 951-8. (Pubitemid 37163248)
58. Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006; 17: 1253-61. (Pubitemid 44772825)
59. Saarinen NM, Wärri A, Mäkelä SI, Eckerman C, Reunanen M, Ahotupa M, et al. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 2000; 36: 207-16. (Pubitemid 30437042)
60. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 1982; 2: 1295-9.
61. Adlercreutz H, Höckerstedt K, Bannwart C, Hämäläinen E, Fotsis T, Bloigu S. Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: Bresciani F, King RJB, Lippman ME, Raynaud J-P, eds. Progress in cancer research and therapy, Vol 35: hormones and cancer 3. New York: Raven Press; 1988. pp. 409-12.
62. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990-4. (Pubitemid 27421108)
63. Burkitt DP. Colonic-rectal cancer: fiber and other dietary factors. Amer J Clin Nutr 1978; 31: S58-64. (Pubitemid 9058928)
64. Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliövaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer 2000; 82: 1107-10. (Pubitemid 30128864)
65. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. Jama J Am Med Assn 2004; 291: 827-35. (Pubitemid 38543770)
66. Rodriguez LAG, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Amer J Epidemiol 2005; 161: 616-9. (Pubitemid 40411089)
67. Sørensen HT, Skriver MV, Friis S, McLaughlin J, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Brit J Cancer 2005; 92: 594-6. (Pubitemid 40395544)
68. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population - The Bay Area Breast Cancer Study. Amer J Epidemiol 2001; 154: 434-41. (Pubitemid 32845481)
69. Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002; 13: 407-15. (Pubitemid 34666596)
70. Stumpf K. Serum enterolactone as a biological marker and in breast cancer: from laboratory to epidemiological studies. Helsinki: University of Helsinki; 2004. p. 157.
71. Mazur WM, Wähälä K, Rasku S, Salakka A, Hase T, Adlercreutz H. Lignan and isoflavonoid concentrations in tea and coffee. Br J Nutr 1998; 79: 37-45. (Pubitemid 28058593)
72. Stumpf K, Pietinen P, Puska P, Wang G, Adlercreutz H. Determination of serum enterolactone, genistein and daidzein in samples from the North Karelian intervention study. Cancer Epidem Biomark Prev 2001; 9: 1369-72.
73. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, et al. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Brit J Cancer 2004; 91: 99-105. (Pubitemid 39013052)
74. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991; 16: 43-52.
75. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, Li DH, et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 2005; 51: 162-9. (Pubitemid 40734716)
76. Touillaud MS, Thiebaut AC, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidem Biomark Prev 2006; 15: 2574-6. (Pubitemid 46048325)
77. Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU. Dietary phytoestrogen intake - lignans and isoflavones - and breast cancer risk (Canada). Cancer Causes Control 2008; 19: 259-72.
78. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, et al. Enterolactone is differently associated with estrogen receptor ß-negative and -positive breast cancer in a Swedish nested case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 3241-51.
79. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, Lopez-Carrillo L. Dietary consumption of phytochemicals and breast cancer risk in Mexican women. Public Health Nutrition 2008; 12: 825-31.
80. Sonestedt E, Ivarsson MI, Harlid S, Ericson U, Gullberg B, Carlson J, et al. The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes. J Nutr 2009; 139: 993-1001.
81. Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 2010; 91: 440-48.
82. Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J. CYP17 genotypes modifies the association between lignan supply and premenopausal breast cancer risk in humans. J Nutr 2006; 136: 1596-603. (Pubitemid 43765368)
83. Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A. Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 2008; 98: 636-40. (Pubitemid 351214515)
84. Linseisen J, Piller R, Hermann S, ChangClaude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2004; 110: 284-90. (Pubitemid 38580404)
85. Piller RA, Chang-Claude JB, Linseisen JAB. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 2006; 15: 225-32.
86. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 2004; 111: 440-3. (Pubitemid 38998827)
87. McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, et al. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 2006; 99: 309-11. (Pubitemid 44337923)
88. Boccardo F, Lunardi GL, Petti AR, Rubagotti A. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. Breast Cancer Res Treat 2003; 79: 17-23. (Pubitemid 36561039)
89. Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, et al. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 2004; 40: 84-9. (Pubitemid 37542321)
90. Boccardo F, Puntoni M, Guglielmini P, Rubagotti AU. Enterolactone as a risk factor for breast cancer: a review of the published evidence. Clin Chim Acta 2006; 365: 58-67. (Pubitemid 43196417)
91. Aubertin-Leheudre M, Koskela A, Samaletdin A, Adlercreutz H. Plasma alkylresorcinol metabolites as potential biomarkers of whole-grain wheat and rye cereal fibre intakes in women. Br J Nutr 2010; 103: 339-43.
92. Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002; 41: 168-76. (Pubitemid 36056326)
93. Ha TC, Lyons-Wall PM, Moore DE, Tattam BN, Boyages J, Ung OA, et al. Phytoestrogens and indicators of breast cancer prognosis. Nutr Cancer 2006; 56: 3-10.
94. den Tonkelaar I, Keinan-Boker L, Van't Veer P, Arts CJM, Adlercreutz H, Thijssen JHH, et al. Urinary phyto-oestrogens and breast cancer risk in a Western population. Cancer Epidem Biomark Prev 2001; 10: 223-8. (Pubitemid 34288533)
95. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidem Biomark Prev 2004; 13: 698-708. (Pubitemid 38737856)
96. Keinan-Boker L, van der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004; 79: 282-8. (Pubitemid 41095982)
97. Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomark Prev 2007; 16: 451-7. (Pubitemid 46548648)
98. Kozubek A, Nienartowicz B. Cereal grain resorcinolic lipids inhibit H2O2-induced peroxidation of biological membranes. Acta Biochim Pol 1995; 42: 309-15.
99. Aubertin-Leheudre M, Koskela A, Samaletdin A, Adlercreutz H. Plasma and urinary alkylresorcinol metabolites as potential biomarkers of breast cancer risk in Finnish women: a pilot study. Nutr Cancer 2010; 62: 759-64.